Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
about
Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response.Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionLiterature update 2000, part 1.Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cellsCharacteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies.Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathway.Alpha-Gal detectors in xenotransplantation research: a word of caution.First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity.Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies.Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies.Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.Different approaches to heart valve decellularization: A comprehensive overview of the past 30 years.Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal diseaseBiocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices
P2860
Q33752292-2BC80254-5320-4B56-BA7E-B6B4F959B887Q34018912-96EC91D1-25B6-4EE6-94AF-4867D0CF7AA1Q34054806-90F2B40E-E401-42B3-9297-D0C88C28DE75Q34674677-409DFDEF-769D-4324-9ED2-7115FBAAFE9AQ36304925-D20BF300-F0C1-4A41-8FF5-D7B9CD1BB82AQ36965221-B90079DB-D62E-465A-8F68-EC2A0C48F205Q38036376-FA1DBE8F-7F92-42DC-A09B-7EC0F0EE71F0Q39382269-ADC23162-27E2-48A3-AFF7-692B45C6B471Q40826290-69896CA7-5228-4975-AB38-66F6C89DF764Q44117365-BD865F91-CA08-4D17-838D-B0DFA06E11B3Q44316818-C1DEF911-3E5A-4F48-BBCE-3F73BCD9E7D4Q44852485-533CE346-42C5-42AC-80C7-7A2A0EDFDB41Q45252437-CA346D33-3BB6-40BE-AA79-1571EE560EA6Q47422814-15DDA53D-AF88-41EC-ABBE-08CA7FF71B13Q58476742-44E96C40-5736-4825-B3CA-68ADD4F950DAQ59052137-0F71A150-CB9D-40B3-B49C-03427B1D0E38
P2860
Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Xenotransplantation: in vitro ...... ->3Gal IgM and IgG antibodies.
@en
type
label
Xenotransplantation: in vitro ...... ->3Gal IgM and IgG antibodies.
@en
prefLabel
Xenotransplantation: in vitro ...... ->3Gal IgM and IgG antibodies.
@en
P2093
P356
P1433
P1476
Xenotransplantation: in vitro ...... ->3Gal IgM and IgG antibodies.
@en
P2093
Joziasse DH
Korchagina EY
Mohacsi PJ
Nifant'ev NE
Tsvetkov DE
P304
P356
10.1093/GLYCOB/10.2.141
P577
2000-02-01T00:00:00Z